<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>15572</id><no>STUDY00006757</no><status>Open</status><title>Personalized Oncology Promoting Equity for Black Lives (PROPEL)</title><secondary_protocol_no>1R01CA277599</secondary_protocol_no><nct_id>NCT06073626</nct_id><sponsor_type>National</sponsor_type><age_group>Adult</age_group><treatment_type>Screening</treatment_type><phase>N/A (Cancer Control) (Cancer Prevention)</phase><cancer_control>Y</cancer_control><cancer_prevention>Y</cancer_prevention><scope>National</scope><disease_site>Other</disease_site><PI>Schwartz, Marc</PI><institution>Lombardi Comprehensive Cancer Center : Chris Grisham, Lia Sorgen; Rutgers Cancer Institute of New Jersey</institution><oncology_group>Population Science<DOWG_name>Oncology Group</DOWG_name></oncology_group><management_group>Lombardi Comprehensive Cancer Center (LCCC)</management_group><item><contact_id>11843</contact_id><item_description>Lia Sorgen</item_description><js_safe_str>Lia Sorgen</js_safe_str><email>ls1430@georgetown.edu</email></item><item><contact_id>14384</contact_id><item_description>Chris Grisham</item_description><js_safe_str>Chris Grisham</js_safe_str><email>cjg93@georgetown.edu</email></item></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>